128 related articles for article (PubMed ID: 35016131)
41. Corrigendum to "MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas" [Eur. J. Radiol. 113 (2019) 7-14].
Hu XX; Wang WT; Yang L; Yang ZX; Liang HY; Ding Y; Ji Y; Zeng MS; Rao SX
Eur J Radiol; 2019 May; 114():193. PubMed ID: 31007181
[No Abstract] [Full Text] [Related]
42. Corrigendum to "The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis - Randomized study". [Eur. J. Radiol. 142 (2021) 109830].
Andrasina T; Rohan T; Panek J; Kovalcikova P; Kunovsky L; Ostrizkova L; Valek V
Eur J Radiol; 2022 Mar; 148():110180. PubMed ID: 35114534
[No Abstract] [Full Text] [Related]
43. Corrigendum to "Three tesla and 3D multiparametric combined imaging evaluation of axial spondyloarthritis and pelvic enthesopathy" [Eur. J. Radiol. (2020) 108916].
Chhabra A; Ezzati F; Taurog JD; Xi Y; Pezeshk P
Eur J Radiol; 2020 Nov; 132():109260. PubMed ID: 32956999
[No Abstract] [Full Text] [Related]
44. Corrigendum to "Detection of visual and frontoparietal network perfusion deficits in Parkinson's disease dementia" [Eur. J. Radiol. 144 (2021) 109985].
Azamat S; Arslan DB; Erdogdu E; Kicik A; Cengiz S; Eryürek K; Tufekcioğlu Z; Bilgic B; Hanagasi H; Demiralp T; Gurvit H; Ozturk-Isik E
Eur J Radiol; 2022 Dec; 157():110570. PubMed ID: 36327858
[No Abstract] [Full Text] [Related]
45. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
[TBL] [Abstract][Full Text] [Related]
46. Corrigendum to "Investigating changes in axonal density and morphology of glaucomatous optic nerves using fixel-based analysis" [Eur. J. Radiol. 133, December, 2020, 109356].
Haykal S; Jansonius NM; Cornelissen FW
Eur J Radiol; 2021 Mar; 136():109555. PubMed ID: 33500151
[No Abstract] [Full Text] [Related]
47. Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the "target sign" a common finding?
Ha S; Lee CH; Kim BH; Park YS; Lee J; Choi JW; Kim KA; Park CM
Magn Reson Imaging; 2012 Oct; 30(8):1083-90. PubMed ID: 22578929
[TBL] [Abstract][Full Text] [Related]
48. Enhanced Rim on MDCT of Colorectal Liver Metastases: Assessment of Ability to Predict Progression-Free Survival and Response to Bevacizumab-Based Chemotherapy.
Cheng J; Qiu M; Zhang Y; Hong N; Shen D; Zhou J; Wang Y
AJR Am J Roentgenol; 2020 Dec; 215(6):1377-1383. PubMed ID: 32991216
[No Abstract] [Full Text] [Related]
49. Corrigendum to "INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma" [Eur. J. Radiol. 166 (2023) 111012].
Schoot RA; van Ewijk R; von Witzleben AA; Kao SC; Hans Merks JHM; Morosi C; Pace E; Shulkin BL; Ferrari A; von Kalle T; van Rijn RR; Weiss AR; Sparber-Sauer M; Ter Horst SAJ; Beth McCarville M
Eur J Radiol; 2023 Nov; 168():111108. PubMed ID: 37774530
[No Abstract] [Full Text] [Related]
50. Corrigendum to "Overview of trials on artificial intelligence algorithms in breast cancer screening - A roadmap for international evaluation and implementation" [Eur. J. Radiol. 167 (2023) 111087].
van Nijnatten TJA; Payne NR; Hickman SE; Ashrafian H; Gilbert FJ
Eur J Radiol; 2024 Jan; 170():111202. PubMed ID: 37988959
[No Abstract] [Full Text] [Related]
51. Corrigendum to "Atherosclerotic carotid artery disease Radiomics: A systematic review with meta-analysis and radiomic quality score assessment" [Eur. J. Radiol. 177 (2024) 111547].
Vacca S; Scicolone R; Gupta A; Allan Wasserman B; Song J; Nardi V; Yang Q; Benson J; Lanzino G; Paraskevas KI; Suri JS; Saba L
Eur J Radiol; 2024 Jun; 177():111583. PubMed ID: 38944908
[No Abstract] [Full Text] [Related]
52. Computed tomographic appearances of colorectal liver metastases.
Chamadol N; Laopaiboon V; Ruangwattanapaisarn N; Khuntikeo N; Pairojkul C
J Med Assoc Thai; 2011 Jul; 94(7):826-32. PubMed ID: 21774290
[TBL] [Abstract][Full Text] [Related]
53. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
[TBL] [Abstract][Full Text] [Related]
54. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
[TBL] [Abstract][Full Text] [Related]
55. Corrigendum to "Evaluation of breast cancer malignancy, prognostic factors and molecular subtypes using a continuous-time random-walk MR diffusion model" [Eur. J. Radiol. 166 (2023) 111003].
Chang H; Wang D; Li Y; Xiang S; Yang YX; Kong P; Fang C; Ming L; Wang X; Zhang C; Jia W; Yan Q; Liu X; Zeng Q
Eur J Radiol; 2023 Dec; 169():111158. PubMed ID: 37897958
[No Abstract] [Full Text] [Related]
56. Corrigendum to "Ultra-low dose abdominal MDCT: Using a knowledge-based Iterative Model Reconstruction technique for substantial dose reduction in a prospective clinical study" [Eur. J. Radiol. 84 (2015) 2-10].
Khawaja RDA; Singh S; Blake M; Harisinghani M; Choy G; Karaosmanoglu A; Padole A; Do S; Brown K; Thompson R; Morton T; Raihani N; Koehler T; Kalra MK
Eur J Radiol; 2016 Jan; 85(1):310. PubMed ID: 28676321
[No Abstract] [Full Text] [Related]
57. Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.
Klinger M; Tamandl D; Eipeldauer S; Hacker S; Herberger B; Kaczirek K; Dorfmeister M; Gruenberger B; Gruenberger T
Ann Surg Oncol; 2010 Aug; 17(8):2059-65. PubMed ID: 20177795
[TBL] [Abstract][Full Text] [Related]
58. Assessment of colorectal hepatic metastases by quantitative T2 relaxation time.
Raza SA; Funicelli L; Sohaib SA; Collins DJ; Scurr E; Leach MO; Koh DM
Eur J Radiol; 2012 Apr; 81(4):e536-40. PubMed ID: 21724358
[TBL] [Abstract][Full Text] [Related]
59. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
[TBL] [Abstract][Full Text] [Related]
60. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
Ghorra C; Pommier R; Piveteau A; Rubbia-Brandt L; Vilgrain V; Terraz S; Ronot M
Eur Radiol; 2021 Apr; 31(4):2451-2460. PubMed ID: 33025173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
